RadBook 2013

ITSYSTEMSRAD·BOOK 2013 71 search Center (DKFZ) in Heidelberg started to address this need by develop- ing mint Lesion, a dedicated workflow solution to efficiently assess lesions throughout the course of therapy. mint Lesion is specifically designed to streamline the read process: it covers management of patient cohorts in the context of disease and treatment, as- sessment of lesions with respect to the overall course of therapy, statistical re- sponse evaluation in line with response criteria such as RECIST, and consistent and comprehensive automated report- ing. In a matter of seconds, lesions are tracked in follow-up image data and assessed consistently. Due to the seam- less integration with systems of vari- ous vendors, radiologists can provide clinicians with automatically generated notes, diagrams, and tables as a key ele- ment of their RIS report. Tumor boards can access relevant image and report data directly from the PACS viewer. Simplicity and effectiveness of mint Lesion in daily use also inspired Prof. Dr. Hans-Christoph Becker: “With mint Lesion, for the first time I now have a complete overview on all stud- ies and follow-up assessments of my patients – at a glance.“ Considering the modern therapies and increasingly multi-modal therapy approaches, new challenges and oppor- tunities arise for oncological therapy and radiological image-based diagno- sis. “The clinicians’ call for assessment criteria that document the response and the progression of lesions in a standardized way is getting louder and louder,” says Prof. Dr. Hans-Christoph Becker from the Ludwig Maximilians University of Munich. Radiological therapy response assessment is chal- lenging, and proper response assess- ment and reporting in the context of the overall therapy course are crucial. An inconsistent assessment or a delay in detection of progression might re- sult in a late switch of therapy, which in turn might implicate serious conse- quences for the patient. In 2009, radiologists and computer scientists of the German Cancer Re- Accentuated quality and impact of oncological radiology with mint Lesion SimplicityandEffectiveness www.mint-medical.de „With mint Lesion, for the first time I now have a complete overview on all studies and follow-up assessments of my patients – at a glance.“ Prof. Hans-Christoph Becker Ludwig Maximilians University Munich, Germany Since 2000 the Response Evaluation Criteria In Solid Tumors (RECIST) has been the international standard for therapy monitoring in oncology. Initially, RECIST was mainly applied in clinical trials. Today, standardized therapy monitoring is becoming more and more rele- vant for clinical routine as well. In addition, modern targeted therapies play an increasingly important role in the treatment of cancer patients, and their evaluation requires more sensitive criteria. The dedicated clinical application mint Lesion allows for a streamlined and consistent assessment of longitudinal reads in line with various response criteria. Specifically designed to streamline the read process: mint Lesion supports radiologists and oncologists in assessing the effectiveness of a cancer therapy.

RadBook 2013

Pages